Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue GuidanceBusiness Wire • 11/06/25
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual MeetingBusiness Wire • 10/21/25
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025Business Wire • 10/16/25
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet TransfusionsBusiness Wire • 08/25/25
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025Business Wire • 08/21/25
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025Business Wire • 07/22/25
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic InjuryBusiness Wire • 07/21/25
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application UpdateBusiness Wire • 07/02/25
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025Business Wire • 06/03/25
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in MilanBusiness Wire • 05/29/25
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination DeviceBusiness Wire • 05/28/25
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025Business Wire • 04/17/25
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)Business Wire • 03/05/25
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial ResultsBusiness Wire • 02/20/25
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care ConferenceBusiness Wire • 02/19/25
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025Business Wire • 02/07/25
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business UpdateBusiness Wire • 01/13/25